Fny Investment Advisers, LLC Lian Bio Transaction History

Fny Investment Advisers, LLC

$237 Million
Q2 2025

A detailed history of Fny Investment Advisers, LLC transactions in Lian Bio stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 14,000 shares of LIAN stock, worth $5,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,000

Previous 14,700 4.76%

Holding current value

$5,880

Previous $2,000 150.0%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	SELL	$0.32 - $0.42 $224 - $294	-700 Reduced 4.76%	14,000 $5,000
Q1 2025 Apr 17, 2025	BUY	$0.19 - $0.32 $95 - $160	500 Added 3.52%	14,700 $2,000
Q4 2024 Jan 13, 2025	BUY	$0.29 - $0.3 $115 - $120	400 Added 2.9%	14,200 $3,000
Q1 2024 May 02, 2024	BUY	$0.3 - $4.99 $4,140 - $68,862	13,800 New	13,800 $4,000
Q2 2022 Jul 12, 2022	SELL	$2.15 - $6.01 $1,720 - $4,808	-800 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$2.8 - $6.21 $2,240 - $4,968	800 New	800 $2,000

Others Institutions Holding LIAN

# of Institutions

Shares Held

14K

Call Options Held

Put Options Held

View Full List

About LianBio

Ticker LIAN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,354,000
Market Cap $45.5M
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...

More about LIAN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Account

Fny Investment Advisers, LLC Lian Bio Transaction History